Novartis and Microsoft Partner to Transform Medicine with AI
Inside Digital Health | October 01, 2019
Novartis today announced the founding of its artificial intelligence (AI) innovation lab and a strategic partnership with Microsoft. The collaboration aims to use AI and data science to transform medicine and computational challenges within life sciences. The lab could bolster the Swiss pharmaceutical giant’s AI capabilities and help accelerate the discovery of transformative medicines. Together, we aim to address some of the biggest challenges facing the life sciences industry today and bring AI capabilities to every Novartis employee so they can unlock new insights as they work to discover new medicines and reduce patient costs, said Satya Nadella, CEO of Microsoft. (AI) offers huge potential to transform healthcare and the way we understand health, said Shahram Ebadollahi, Ph.D., the global head of data and AI at Novartis, and Ann Aerts, M.D., head of the Novartis Foundation. It can shift countries’ health systems from being reactive to proactive and even predictive.